The downgrade is the result of a number of factors, including the health system’s large operating loss and unexpected liquidity decline in fiscal year 2016 and expected further liquidity decline and lower margins than previous projections indicated.
The outlook is stable, reflecting Moody’s Investors Service’s expectation the health system will maintain adequate liquidity and will not face incremental leverage.
More articles on healthcare finance:
S&P raises rating on Baptist Health’s bonds to ‘AA’
Moody’s affirms ‘Baa2’ rating on Jupiter Medical Center’s bonds
Moody’s affirms ‘Aa3’ rating on Mercy Health’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
